Stocks
Bio-Rad Laboratories, Inc.BIO
NYSEHealthcareBiotechnology$262.80+0.37%
A global leader in life science research and clinical diagnostics products, Bio-Rad Laboratories develops and markets specialized technologies used in biotechnology, pharmaceutical, and academic research. Investors monitor the company for its strong position in PCR equipment, immunoassays, and protein separation systems, which are critical tools for scientific discovery and medical testing.
Market Cap: $7.1B52W Range: $211.43 – $343.12
Congressional Interest in Bio-Rad Laboratories, Inc. (BIO)
9 members of Congress have disclosed 32 trades in Bio-Rad Laboratories, Inc. (BIO), a Healthcare company. The buy/sell breakdown shows 14 purchases versus 17 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
32
Unique Politicians
9
Buys
14
Sells
17
Who in Congress Is Trading BIO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-03-08 | Rohit Khanna | buy | $1K – $15K |
| 2023-11-03 | Rohit Khanna | buy | $1K – $15K |